Document is current
Any future updates will be listed below
-
Authors
Gómez-Sánchez, Miguel
Blanco-González, Elisa
Montes-Bayón, María
Behe, Martin
Schibli, Roger
Rioja-Blanco, Elisa https://orcid.org/0000-0003-4176-8772
-
Funding
Funding for this research was provided by:
Swiss Federal Institute of Technology Zurich
- License Information
-
More Information
Article History
Received: 23 January 2026
Accepted: 10 March 2026
First Online: 1 April 2026
Declarations
:
: Not applicable.
: Not applicable.
: ERB, RS, and MB are cited as inventors in a patent application covering CD30-targeting antibody-radioligand conjugates and their therapeutic use (EP24178074.1). RS and MB are co-founders of Araris Biotech AG and co-inventors in other patents. MB is an associated editor of the journal EJNMMI Radiopharmacy and Chemistry.
